3D Bioprinting for Life Science R&D Market - Global Outlook and Forecast 2023-2027

Report ID: 867100 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 3D Bioprinting for Life Science R&D Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global 3D Bioprinting for Life Science R&D Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global 3D Bioprinting for Life Science R&D Overall Market Size
    2.1 Global 3D Bioprinting for Life Science R&D Market Size: 2021 VS 2027
    2.2 Global 3D Bioprinting for Life Science R&D Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top 3D Bioprinting for Life Science R&D Players in Global Market
    3.2 Top Global 3D Bioprinting for Life Science R&D Companies Ranked by Revenue
    3.3 Global 3D Bioprinting for Life Science R&D Revenue by Companies
    3.4 Top 3 and Top 5 3D Bioprinting for Life Science R&D Companies in Global Market, by Revenue in 2020
    3.5 Global Companies 3D Bioprinting for Life Science R&D Product Type
    3.6 Tier 1, Tier 2 and Tier 3 3D Bioprinting for Life Science R&D Players in Global Market
        3.6.1 List of Global Tier 1 3D Bioprinting for Life Science R&D Companies
        3.6.2 List of Global Tier 2 and Tier 3 3D Bioprinting for Life Science R&D Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global 3D Bioprinting for Life Science R&D Market Size Markets, 2021 & 2027
        4.1.2 Magnetic 3D Bioprinting
        4.1.3 Laser-Assisted Bioprinting
        4.1.4 Inkjet 3D Bioprinting
        4.1.5 Microextrusion 3D Bioprinting
    4.2 By Type - Global 3D Bioprinting for Life Science R&D Revenue & Forecasts
        4.2.1 By Type - Global 3D Bioprinting for Life Science R&D Revenue, 2016-2021
        4.2.2 By Type - Global 3D Bioprinting for Life Science R&D Revenue, 2022-2027
        4.2.3 By Type - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global 3D Bioprinting for Life Science R&D Market Size, 2021 & 2027
        5.1.2 Clinical
        5.1.3 Research
    5.2 By Application - Global 3D Bioprinting for Life Science R&D Revenue & Forecasts
        5.2.1 By Application - Global 3D Bioprinting for Life Science R&D Revenue, 2016-2021
        5.2.2 By Application - Global 3D Bioprinting for Life Science R&D Revenue, 2022-2027
        5.2.3 By Application - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global 3D Bioprinting for Life Science R&D Market Size, 2021 & 2027
    6.2 By Region - Global 3D Bioprinting for Life Science R&D Revenue & Forecasts
        6.2.1 By Region - Global 3D Bioprinting for Life Science R&D Revenue, 2016-2021
        6.2.2 By Region - Global 3D Bioprinting for Life Science R&D Revenue, 2022-2027
        6.2.3 By Region - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America 3D Bioprinting for Life Science R&D Revenue, 2016-2027
        6.3.2 US 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.3.3 Canada 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.3.4 Mexico 3D Bioprinting for Life Science R&D Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe 3D Bioprinting for Life Science R&D Revenue, 2016-2027
        6.4.2 Germany 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.3 France 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.4 U.K. 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.5 Italy 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.6 Russia 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.7 Nordic Countries 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.4.8 Benelux 3D Bioprinting for Life Science R&D Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia 3D Bioprinting for Life Science R&D Revenue, 2016-2027
        6.5.2 China 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.5.3 Japan 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.5.4 South Korea 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.5.5 Southeast Asia 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.5.6 India 3D Bioprinting for Life Science R&D Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America 3D Bioprinting for Life Science R&D Revenue, 2016-2027
        6.6.2 Brazil 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.6.3 Argentina 3D Bioprinting for Life Science R&D Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa 3D Bioprinting for Life Science R&D Revenue, 2016-2027
        6.7.2 Turkey 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.7.3 Israel 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.7.4 Saudi Arabia 3D Bioprinting for Life Science R&D Market Size, 2016-2027
        6.7.5 UAE 3D Bioprinting for Life Science R&D Market Size, 2016-2027
7 Players Profiles
    7.1 EnvisionTEC
        7.1.1 EnvisionTEC Corporate Summary
        7.1.2 EnvisionTEC Business Overview
        7.1.3 EnvisionTEC 3D Bioprinting for Life Science R&D Major Product Offerings
        7.1.4 EnvisionTEC 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.1.5 EnvisionTEC Key News
    7.2 Regenovo
        7.2.1 Regenovo Corporate Summary
        7.2.2 Regenovo Business Overview
        7.2.3 Regenovo 3D Bioprinting for Life Science R&D Major Product Offerings
        7.2.4 Regenovo 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.2.5 Regenovo Key News
    7.3 Organovo
        7.3.1 Organovo Corporate Summary
        7.3.2 Organovo Business Overview
        7.3.3 Organovo 3D Bioprinting for Life Science R&D Major Product Offerings
        7.3.4 Organovo 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.3.5 Organovo Key News
    7.4 3D Systems
        7.4.1 3D Systems Corporate Summary
        7.4.2 3D Systems Business Overview
        7.4.3 3D Systems 3D Bioprinting for Life Science R&D Major Product Offerings
        7.4.4 3D Systems 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.4.5 3D Systems Key News
    7.5 3D Biotek
        7.5.1 3D Biotek Corporate Summary
        7.5.2 3D Biotek Business Overview
        7.5.3 3D Biotek 3D Bioprinting for Life Science R&D Major Product Offerings
        7.5.4 3D Biotek 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.5.5 3D Biotek Key News
    7.6 Advanced Biomatrix
        7.6.1 Advanced Biomatrix Corporate Summary
        7.6.2 Advanced Biomatrix Business Overview
        7.6.3 Advanced Biomatrix 3D Bioprinting for Life Science R&D Major Product Offerings
        7.6.4 Advanced Biomatrix 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.6.5 Advanced Biomatrix Key News
    7.7 Digilab
        7.7.1 Digilab Corporate Summary
        7.7.2 Digilab Business Overview
        7.7.3 Digilab 3D Bioprinting for Life Science R&D Major Product Offerings
        7.4.4 Digilab 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.7.5 Digilab Key News
    7.8 Nano3D Biosciences
        7.8.1 Nano3D Biosciences Corporate Summary
        7.8.2 Nano3D Biosciences Business Overview
        7.8.3 Nano3D Biosciences 3D Bioprinting for Life Science R&D Major Product Offerings
        7.8.4 Nano3D Biosciences 3D Bioprinting for Life Science R&D Revenue in Global (2016-2021)
        7.8.5 Nano3D Biosciences Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. 3D Bioprinting for Life Science R&D Market Opportunities & Trends in Global Market
    Table 2. 3D Bioprinting for Life Science R&D Market Drivers in Global Market
    Table 3. 3D Bioprinting for Life Science R&D Market Restraints in Global Market
    Table 4. Key Players of 3D Bioprinting for Life Science R&D in Global Market
    Table 5. Top 3D Bioprinting for Life Science R&D Players in Global Market, Ranking by Revenue (2019)
    Table 6. Global 3D Bioprinting for Life Science R&D Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. Global 3D Bioprinting for Life Science R&D Revenue Share by Companies, 2016-2021
    Table 8. Global Companies 3D Bioprinting for Life Science R&D Product Type
    Table 9. List of Global Tier 1 3D Bioprinting for Life Science R&D Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 3D Bioprinting for Life Science R&D Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - 3D Bioprinting for Life Science R&D Revenue in Global (US$, Mn), 2016-2021
    Table 13. By Type - 3D Bioprinting for Life Science R&D Revenue in Global (US$, Mn), 2022-2027
    Table 14. By Application – Global 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - 3D Bioprinting for Life Science R&D Revenue in Global (US$, Mn), 2016-2021
    Table 16. By Application - 3D Bioprinting for Life Science R&D Revenue in Global (US$, Mn), 2022-2027
    Table 17. By Region – Global 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2021 VS 2027
    Table 18. By Region - Global 3D Bioprinting for Life Science R&D Revenue (US$, Mn), 2016-2021
    Table 19. By Region - Global 3D Bioprinting for Life Science R&D Revenue (US$, Mn), 2022-2027
    Table 20. By Country - North America 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2021
    Table 21. By Country - North America 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2022-2027
    Table 22. By Country - Europe 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2021
    Table 23. By Country - Europe 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2022-2027
    Table 24. By Region - Asia 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2021
    Table 25. By Region - Asia 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2022-2027
    Table 26. By Country - South America 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - South America 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - Middle East & Africa 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2021
    Table 29. By Country - Middle East & Africa 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2022-2027
    Table 30. EnvisionTEC Corporate Summary
    Table 31. EnvisionTEC 3D Bioprinting for Life Science R&D Product Offerings
    Table 32. EnvisionTEC 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 33. Regenovo Corporate Summary
    Table 34. Regenovo 3D Bioprinting for Life Science R&D Product Offerings
    Table 35. Regenovo 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 36. Organovo Corporate Summary
    Table 37. Organovo 3D Bioprinting for Life Science R&D Product Offerings
    Table 38. Organovo 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 39. 3D Systems Corporate Summary
    Table 40. 3D Systems 3D Bioprinting for Life Science R&D Product Offerings
    Table 41. 3D Systems 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 42. 3D Biotek Corporate Summary
    Table 43. 3D Biotek 3D Bioprinting for Life Science R&D Product Offerings
    Table 44. 3D Biotek 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 45. Advanced Biomatrix Corporate Summary
    Table 46. Advanced Biomatrix 3D Bioprinting for Life Science R&D Product Offerings
    Table 47. Advanced Biomatrix 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 48. Digilab Corporate Summary
    Table 49. Digilab 3D Bioprinting for Life Science R&D Product Offerings
    Table 50. Digilab 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
    Table 51. Nano3D Biosciences Corporate Summary
    Table 52. Nano3D Biosciences 3D Bioprinting for Life Science R&D Product Offerings
    Table 53. Nano3D Biosciences 3D Bioprinting for Life Science R&D Revenue (US$, Mn), (2016-2021)
List of Figures
    Figure 1. 3D Bioprinting for Life Science R&D Segment by Type
    Figure 2. 3D Bioprinting for Life Science R&D Segment by Application
    Figure 3. Global 3D Bioprinting for Life Science R&D Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global 3D Bioprinting for Life Science R&D Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global 3D Bioprinting for Life Science R&D Revenue, 2016-2027 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by 3D Bioprinting for Life Science R&D Revenue in 2020
    Figure 8. By Type - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 9. By Application - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 10. By Region - Global 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 11. By Country - North America 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 12. US 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 13. Canada 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 14. Mexico 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 15. By Country - Europe 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 16. Germany 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 17. France 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 18. U.K. 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 19. Italy 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 20. Russia 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 21. Nordic Countries 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 22. Benelux 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 23. By Region - Asia 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 24. China 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 25. Japan 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 26. South Korea 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 27. Southeast Asia 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 28. India 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 29. By Country - South America 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 30. Brazil 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 31. Argentina 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 32. By Country - Middle East & Africa 3D Bioprinting for Life Science R&D Revenue Market Share, 2016-2027
    Figure 33. Turkey 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 34. Israel 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 35. Saudi Arabia 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 36. UAE 3D Bioprinting for Life Science R&D Revenue, (US$, Mn), 2016-2027
    Figure 37. EnvisionTEC 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 38. Regenovo 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 39. Organovo 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 40. 3D Systems 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 41. 3D Biotek 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 42. Advanced Biomatrix 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 43. Digilab 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 44. Nano3D Biosciences 3D Bioprinting for Life Science R&D Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
3D Bioprinting for Life Science R&D Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
3D Bioprinting for Life Science R&D Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
3D Bioprinting for Life Science R&D Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports